| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.36 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.05 |